Skip to main content
CRS 2025 Annual Meeting & Exposition Main banner
Final Program


CRS Abstract Guide

Alternative Methods to Animal Testing
Technical Session

Tech Session IV: Alternative Methods to Animal Testing I

Wednesday, July 16, 2025
2:00 PM - 4:00 PM EDT
Location: 125

    Chair(s)

  • Bruno Sarmento, PhD (he/him/his)

    Principal Investigator
    i3S . Instituto de Investigação e Inovação em Saúde, University of Porto
    Porto, Porto, Portugal

    • Co-Chair(s)

  • Jasmina Lovrić, n/a

    Professor
    Department of Pharmaceutical Technology
    University of Zagreb Faculty of Pharmacy and Biochemistry
    Zagreb, Croatia

Organs-on-a-chip, bioreactors, microfluidic devices, three-dimensional cell assemblies, in vitro recreation of the biological complexity, 3D bioprinting, in vitro / in silico assays to characterize the efficacy, specificity, and toxicity of therapeutic agents.

Presentations:

  • 2:04 PM - 2:29 PM EDT
    Stimuli-responsive bioengineered biomaterials: 3D in vitro models & regenerative medicine therapies

    Oral Abstract Speaker: Silvia Panseri, PhD (she/her/hers) – National Research Council of Italy

  • 2:29 PM - 2:54 PM EDT
    3D(Bio)printed infection models of human lung cells and skin hair follicles to study nanoantibiotics

    Invited Speaker - Exceptional Abstract: Claus-Michael Lehr, PhD – HIPS - Helmholtz Institute for Pharmaceutical Research Saarland & Saarland University, Saarbrücken, Germany

  • 2:54 PM - 3:05 PM EDT
    3D Cell assemblies to evaluate inflammatory response to dual-agent delivery platforms targeting BV

    Oral Abstract Speaker: Arielle D. Greiner, B.S. Biology (she/her/hers) – University of Louisville

  • 3:05 PM - 3:16 PM EDT
    Collagen Microgel 3D Organoid Culture and Extracellular Vesicle Production for Drug Development

    Oral Abstract Speaker: Samantha Ali, MS – University of Florida

  • 3:16 PM - 3:27 PM EDT
    mRNA-LNPs Microneedle Delivery in 3D Human Dermal Equivalent Model for Preliminary In-Vitro Testing

    Oral Abstract Speaker: Elena Lagreca, PhD (she/her/hers) – Istituto italiano di tecnologia

  • 3:27 PM - 3:38 PM EDT
    The SCISSOR technology: Investigating Biopharmaceutics of Subcutaneously Delivered Oligonucleotides

    Oral Abstract Speaker: Karin Somby – Novartis Pharma AG

  • 3:49 PM - 4:00 PM EDT
    The Aβ42:Aβ40 ratio in amyloid plaques and its role in blood-brain barrier dysfunction

    Oral Abstract Speaker: Stefanie Gier, PhD (she/her/hers) – Goethe University Frankfurt